scispace - formally typeset
M

Malgorzata Bartnik

Researcher at Karolinska University Hospital

Publications -  22
Citations -  3987

Malgorzata Bartnik is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Diabetes mellitus & Coronary artery disease. The author has an hindex of 16, co-authored 22 publications receiving 3874 citations. Previous affiliations of Malgorzata Bartnik include Karolinska Institutet.

Papers
More filters
Journal ArticleDOI

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

TL;DR: Guidelines and Expert Consensus documents aim to present management and recommendations based on all of the relevant evidence on a particular subject in order to help physicians to select the best possible management strategies for the individual patient, suffering from a specific condition, taking into account not only the impact on outcome, but also the risk benefit ratio of a particular diagnostic or therapeutic procedure.
Journal ArticleDOI

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

TL;DR: This survey demonstrates that normal glucose regulation is less common than abnormal glucose regulation in patients with CAD and the knowledge of glucometabolic state among these patients should influence their future management because it has great potential to improve the outcome.
Journal ArticleDOI

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases

TL;DR: The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology and the European Association for the Study of Diabetes shows clear trends in survival and morbidity in patients with type 2 diabetes.
Journal ArticleDOI

Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.

TL;DR: Abnormal glucose tolerance is a strong risk factor for future cardiovascular events after myocardial infarction and since it is common and possible to detect even during the hospital phase it is a target for novel secondary preventive efforts.
Journal ArticleDOI

Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: A report from the Euro Heart Survey on diabetes and the heart

TL;DR: It is confirmed that patients with CAD and known diabetes are at high risk for mortality and cardiovascular events and demonstrated that Patients with newly diagnosed diabetes areat intermediate risk for adverse outcomes.